Keep Current with the Latest in Cell Biology Research
Block title
Chromatin Accessibility in Stem Cells Unveils Progressive Transcriptional Alterations in Myelodysplastic Syndrome
[Nature Communications] Researchers showed that the chromatin accessibility profiles of myelodysplastic syndrome stem cells more accurately reflect disease status than those of progenitor cells and reveal the process of stem cell alterations during disease progression.
ACBP/DBI Neutralization for the Prevention and Treatment of Malignant and Non-Malignant Liver Diseases
[Cell Death & Disease] The authors discuss current evidence suggesting that the acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI) system can be targeted for the prevention or treatment of a wide range of liver diseases.
NEK7 Couples SDHB to Orchestrate Respiratory Chain Electron Transport Homeostasis That Impedes Liver Fibrosis
[Nature Communications] Researchers found that NIMA-related kinase 7 (NEK7), targeted to mitochondria by its signal peptides, binds to succinate dehydrogenase complex iron sulfur subunit B (SDHB), stabilizing the spatial conformation of complex II and promoting forward electron transport.
Stabilization of FASN by USP5-Mediated Deubiquitination Promotes Hepatocellular Carcinoma Progression
[Oncogenesis] Scientists demonstrated that ubiquitin specific peptidase 5 (USP5) expression is significantly elevated in HCC tissues. The overexpression of USP5 was closely associated with larger tumor sizes, more satellite nodules and tumor emboli, and predicted unfavorable clinical outcome in HCC patients as well.
Harnessing Alternative Splicing for Off-the-Shelf mRNA Neoantigen Vaccines in Hepatocellular Carcinoma
[Cell Research] Through an integrative analysis of multi-omics data from 279 HCC patients, researchers demonstrated that aberrant splicing events occur at a > 59-fold higher frequency than somatic mutations and generate substantially more immunogenic peptides with broader patient applicability.
Low SVEP1 in Intrahepatic Cholangiocarcinoma Mediates Phenotype Switching-Driven Metastasis by Jag2/Notch1/Hes5
[Cell Death & Disease] Investigators examined the role of SVEP1 in intrahepatic cholangiocarcinoma. Downregulated SVEP1 expression promoted ICC cell proliferation, chemotactic migration, and invasion in vitro, as well as tumor growth and lung metastasis in vivo.
New Liver Cancer Blood Test to Make Detection More Effective and Accessible
[Curtin University] Liver cancer patients may soon be able to check if their disease has returned with a simple blood test that detects tumor-specific DNA changes in the bloodstream, as part of a new Curtin University-led research project.
Discovery of a Carboxyl Fullerene Derivative As a New Lipid Droplet Regulator Inhibiting MASLD
[Gut] Researchers screened biocompatible nanoparticles for anti-metabolic dysfunction-associated steatotic liver disease capacities in vitro by evaluating their regulatory effects on perilipin-2 (PLIN2), the key molecule in lipid droplet formation and stability.
DysUFMylation of SREBP1 Promotes the Progression of Hepatocellular Carcinoma by Reprogramming Lipid Metabolism
[Journal of Clinical and Translational Hepatology] Targeting the UFMylation-sterol regulatory element-binding protein 1 (SREBP1) axis, particularly through fatostatin and lenvatinib combination therapy, represents a novel therapeutic strategy for HCC.
Pyroptosis Modulates Multiple Immune Cell Populations in Targeted Therapy-Treated Melanoma
[Cancer Immunology Research] Using single-cell RNA-sequencing and flow cytometry in BRAFi + MEKi treated melanoma, researchers showed herein that isogenic Gsdme knockout tumors show decreased infiltration with T cells, natural killer cells, and regulatory T cells compared to control tumors.
The Frequency of Regulatory T-Cells in Hashimoto’s Thyroiditis and Graves’ Disease
[Clinical and Experimental Medicine] Investigators compared the number of CD4/CD25/FOXP3 T regulatory cells in the different forms of autoimmune thyroid diseases and in the normal population.
Cellular Immune Endophenotypes Separating Early and Late-Onset Myasthenia Gravis
[JCI Insight] Analyzing two independent cohorts,researchers identified distinct immunological differences driven by three main lymphocyte populations. Lower frequencies of mucosa-associated invariant T cells and naïve CD8 T cells were observed in late-onset myasthenia, suggesting enhanced immune senescence.

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
